Laurus Labs Limited
USFDA
Laurus Labs Vizag API unit gets 1 USFDA observation
Laurus Labs' Unit 6 manufacturing facility is located at Atchutapuram in Visakhapatnam and has 42 reactors with 253 Kilo liters capacity. tnn | November 03, 2018, 07:35 IST
Hyderabad: City-based pharma player Laurus Labs Limited on Friday said it has successfully completed the US Food and Drug Administration (USFDA) audit for its API-intermediates facility Unit-6 with one observation on November 2, 2018.
Laurus Labs' Unit 6 manufacturing facility is located at Atchutapuram in Visakhapatnam and has 42 reactors with 253 Kilo liters capacity.
The company said the USFDA observation following the audit was related to a very minor procedure.
Laurus Labs makes active pharmaceutical ingredients (APIs) for anti-retroviral (ARV), Hepatitis C and oncology drugs as well as other therapeutic areas. The company has also ventured into developing a finished dosages forms on the back of existing strengths in APIs with a current capacity of 5 billion units per year, which is expandable up to 8 billion units per year, the company said.
Tags : Pharma, Laurus Labs Limited, Visakhapatnam, USFDA, pharmaceutical industry, API